phenolsulfonphthalein has been researched along with Acute Confusional Senile Dementia in 3 studies
Phenolsulfonphthalein: Red dye, pH indicator, and diagnostic aid for determination of renal function. It is used also for studies of the gastrointestinal and other systems.
phenol red : 3H-2,1-Benzoxathiole 1,1-dioxide in which both of the hydrogens at position 3 have been substituted by 4-hydroxyphenyl groups. A pH indicator changing colour from yellow below pH 6.8 to bright pink above pH 8.2, it is commonly used as an indicator in cell cultures and in home swimming pool test kits. It is also used in the (now infrequently performed) phenolsulfonphthalein (PSP) test for estimation of overall blood flow through the kidney.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Necula, M | 1 |
Kayed, R | 1 |
Milton, S | 1 |
Glabe, CG | 1 |
Erdogan, M | 1 |
Kilic, B | 1 |
Sagkan, RI | 1 |
Aksakal, F | 1 |
Ercetin, T | 1 |
Gulcan, HO | 1 |
Dogruer, DS | 1 |
Liu, D | 1 |
Zhang, H | 1 |
Wang, Y | 1 |
Liu, W | 1 |
Yin, G | 1 |
Wang, D | 1 |
Li, J | 1 |
Shi, T | 1 |
Wang, Z | 1 |
3 other studies available for phenolsulfonphthalein and Acute Confusional Senile Dementia
Article | Year |
---|---|
Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Animals; Humans; Plaque, Amyloid; Protein Structu | 2007 |
Design, synthesis and biological evaluation of new benzoxazolone/benzothiazolone derivatives as multi-target agents against Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents, N | 2021 |
Design, synthesis, and biological evaluation of carbamate derivatives of N-salicyloyl tryptamine as multifunctional agents for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Binding Sites; Blood-Brain | 2022 |